You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for Patent: 8,071,120


✉ Email this page to a colleague

« Back to Dashboard


Title:Methods for treating neovascularization and intravitreal implants
Abstract: Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.
Inventor(s): Wong; Vernon G. (Menlo Park, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Filing Date:Mar 30, 2006
Application Number:11/393,101
Claims:1. An intravitreal, bioerodible drug delivery system consisting essentially of about 50% by weight dexamethasone effective in preventing or reducing neovascularization in an eye prone to neovascularization, about 15% by weight hydroxypropyl methylcellulose, and about 35% by weight polylactic acid polyglycolic acid (PLGA) copolymer thereby forming an implant for placement into the vitreous of an eye prone to neovascularization.

2. An intravitreal, bioerodible drug delivery system consisting essentially of about 50% by weight dexamethasone effective in preventing or reducing neovascularization in an eye prone to neovascularization, about 15% by weight hydroxypropyl methylcellulose, and about 35% by weight polylactic acid polyglycolic acid (PLGA) copolymer.

3. An intravitreal, bioerodible drug delivery system consisting essentially of about 50% by weight particles of dexamethasone, about 15% by weight hydroxypropyl methylcellulose, and about 35% by weight polylactic acid polyglycolic acid (PLGA) copolymer, wherein the system is effective in releasing the dexamethasone into the eye over a period of at least about 3 weeks, and wherein the intravitreal, bioerodible drug delivery system is a single pellet or a single extruded filament.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.